ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1317

Impairment of Memory in Axial Spondyloarthritis?

Stefan Kleinert1, Florian Schuch2, Praxedis Rapp2, Monika Ronneberger2, Joerg Wendler2, Patrizia Sternad3, Florian Popp3, Peter Bartz-Bazzanella4, Cay Von der Decken5, Kirsten Karberg6, Georg Gauler7, Patrick Wurth8, Susanna Späthling-Mestekemper9, Christoph Kuhn10, Mathias Englbrecht11, Wolfgang Vorbrüggen12, Georg Adler13 and Martin Welcker14, 1Praxisgemeinschaft Rheumatologie - Nephrologie (PGRN), Erlangen, Germany, 2Praxisgemeinschaft Rheumatologie-Nephrologie, Erlangen, Germany, 3Medizinisches Versorgungszentrum für Rheumatologie Dr. M. Welcker GmbH, Planegg, Germany, 4Rhein-Maas Klinikum, Wuerselen, Germany, 5Klinik für Internistische Rheumatologie, Rhein-Maas-Klinikum, Würselen, Germany, 6Praxis für Rheumatologie und Innere Medizin, Berlin, Germany, Berlin, Germany, 7rheumapraxis, Osnabrck, Germany, 8Rheumatologische Schwerpunktpraxis, Osnabrück, Germany, 9Rheumapraxis München, München, Germany, 10Praxis für Rheumatologie, Karlsruhe, Germany, Karlsruhe, Germany, 11Freelance Healthcare Data Scientist, Eckental, Germany., Eckental, Germany, 12Verein zur Förderung der Rheumatologie e.V., Würselen, Germany, 13Institut für Studien zur Psychischen Gesundheit (ISPG), Mannheim, Germany, 14MVZ für Rheumatologie, Planegg, Germany

Meeting: ACR Convergence 2021

Keywords: Cognitive dysfunction, Psoriatic arthritis, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes III: Comorbidities, Extra-muskuloskeletal Manifestations, & Related Conditions (1304–1328)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: There is certain evidence that neuropsychiatric changes occur in systemic lupus(1) and rheumatoid arthritis (2). However, there is little knowledge about possible cognitive changes in axial spondyloarthritis (axSpA). The aim of this study ist to evaluate patients with axial spondyloarthritis regarding cognitive impairments.

Methods: 101 consecutive patients with axial spondyloarthritis attending two rheumatology practices were routinely evaluated by different rheumatologists and underwent a computer-based memory and attention test (MAT) described elsewhere (3, 4). The results of short-term memory and working memory were analyzed compared with an age-, sex- and education-matched control group of healthy subjects.

Results: Patients’ characteristics are displayed in table 1. Patients with axSpA revealed a decreased working memory (table 2) as analysed by Wilcoxon signed-rank test (table 3).

Conclusion: The MAT computerized testing is a highly feasible test and was well accepted by patients. It showed a clinically meaningful decrease in working memory in patients with axial spondyloarthritis. Further work-up is required to characterise possible causes or associations of this cognitive impairment.

Table 1: Patients’ characteristics.

Working Memory and short term memory test results. Patients with spondyloarthritis and an age-, sex, and education-matched controll group.

Wilcoxon signed-rank test revealed a clinically relevant and signficant difference in working memory between patients and controll group.


Disclosures: S. Kleinert, Novartis, 5, Abbvie, 1, Siemens Healthineers, 1, Sanofi, 11; F. Schuch, Abbvie, 1, 6, Novartis, 1, 6, Lilly, 1, Gilead, 1, 6; P. Rapp, None; M. Ronneberger, None; J. Wendler, Janssen Cilag, 1, 6, Roche Pharma, 1, 6; P. Sternad, None; F. Popp, None; P. Bartz-Bazzanella, None; C. Von der Decken, None; K. Karberg, None; G. Gauler, Lilly, 1, Abbvie, 1, 6, Gilead, 6, Novartis, 6; P. Wurth, None; S. Späthling-Mestekemper, None; C. Kuhn, None; M. Englbrecht, None; W. Vorbrüggen, None; G. Adler, None; M. Welcker, Abbvie, 2, 5, 6, Actelion, 5, Aescu, 6, Amgen, 6, Biogen, 6, BMS, 2, 6, Berlin Chemie, 6, Celgene, 2, Galapagos, 2, 5, Gilead, 2, 5, GSK, 2, 5, 6, Hexal, 5, 6, Janssen, 6, Medac, 2, 6, MSD, 6, Mundipharma, 6, Mylan, 2, 6, Novartis, 2, 5, 6, Pfizer, 2, 6, Riemser, 6, Sanofi, 2, 6, UCB, 2, 5, 6.

To cite this abstract in AMA style:

Kleinert S, Schuch F, Rapp P, Ronneberger M, Wendler J, Sternad P, Popp F, Bartz-Bazzanella P, Von der Decken C, Karberg K, Gauler G, Wurth P, Späthling-Mestekemper S, Kuhn C, Englbrecht M, Vorbrüggen W, Adler G, Welcker M. Impairment of Memory in Axial Spondyloarthritis? [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/impairment-of-memory-in-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impairment-of-memory-in-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology